Niagen Bioscience Inc (NASDAQ:NAGE) does about 976.08K shares in volume on a normal day but saw 2161982 shares change hands in the recent trading day. The company now has a market cap of 678.76M USD. Its current market price is $8.73, marking an increase of 3.31% compared to the previous close of $8.45. The 52 week high reached by this stock is $9.18 whilst the lowest price level in 52 weeks is $2.31.
Niagen Bioscience Inc (NAGE) has a 20-day trading average at $7.01 and the current price is -4.90% off the 52-week high compared with 278.74% distance from its 52-week low. The 50-day simple moving average of the closing price is $7.03 and its 200-day simple moving average is $5.33. If we look at the stock’s price movements over the week, volatility stands at 6.68%, which decreases to 6.51% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 71.28 to suggest the stock is overbought.
The consensus objective for the share price is $9.78, suggesting that the stock has a potential upside of 10.74% over the period.
B. Riley Securities also downgraded the stock to “Neutral” from Buy on August 11, 2022 at a price target of $6-$2.40. ROTH Capital initiated its price target at $7.
The current price level is 24.49%, 24.14%, and 63.76% away from its SMA20, SMA50, and SMA200 respectively, with the NAGE price moving below the 50-day SMA on current market day. Niagen Bioscience Inc (NAGE) stock is up 12.21% over the week and 45.14% over the past month. Its price is 64.56% year-to-date and 132.18% over the past year.
To reach the target analysts have set, the stock logically needs to grow 10.74 percent from here.
Outstanding shares total 77.33M with insiders holding 34.48% of the shares and institutional holders owning 30.10% of the company’s common stock. The company has a return on investment of 17.91% and return on equity of 22.94%. The price to earnings ratio (P/E ratio) amounts to 82.91 while the forward price to earnings ratio is 39.68. The beta has a value of 1.99. Price to book ratio is 14.65 and price to sales ratio is 6.81.
